Compounds > cobaltiprotoporphyrin
Page last updated: 2024-09-02

cobaltiprotoporphyrin and Cardiovascular Stroke

cobaltiprotoporphyrin has been researched along with Cardiovascular Stroke in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's5 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abraham, NG; Aravot, D; Hochhauser, E; Issan, Y; Kornowski, R; Laniado-Schwartzman, M; Shainberg, A; Sodhi, K1
Allen, MD; Cao, B; Dennis, JE; Laflamme, MA; Luo, J; Van Biber, B; Weaver, MS1
Allen, MD; Dennis, JE; Laflamme, MA; Luo, J; Weaver, MS; Whalen, E1
DiMaio, JM; Hutcheson, KA; Squiers, JJ; Thatcher, JE1
Forsten, H; Kytö, V; Laine, M; Lakkisto, P; Pulkki, K; Siren, JM; Tikkanen, I1

Other Studies

5 other study(ies) available for cobaltiprotoporphyrin and Cardiovascular Stroke

ArticleYear
Heme oxygenase-1 induction improves cardiac function following myocardial ischemia by reducing oxidative stress.
    PloS one, 2014, Volume: 9, Issue:3

    Topics: Animals; Cells, Cultured; Diabetes Mellitus, Experimental; Enzyme Induction; Heme Oxygenase-1; Male; Membrane Potential, Mitochondrial; Metalloporphyrins; Mice, Inbred C57BL; Myocardial Infarction; Myocardial Ischemia; Myocytes, Cardiac; Oxidative Stress; Proto-Oncogene Proteins c-akt; Protoporphyrins; Rats, Sprague-Dawley

2014
Cobalt protoporphyrin pretreatment protects human embryonic stem cell-derived cardiomyocytes from hypoxia/reoxygenation injury in vitro and increases graft size and vascularization in vivo.
    Stem cells translational medicine, 2014, Volume: 3, Issue:6

    Topics: Animals; Apoptosis; Cell Differentiation; Cell Line; Cell Proliferation; Disease Models, Animal; Embryonic Stem Cells; Enzyme Induction; Female; Graft Survival; Heme Oxygenase-1; Humans; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Myocytes, Cardiac; Neovascularization, Physiologic; Phenotype; Phosphorylation; Proto-Oncogene Proteins c-akt; Protoporphyrins; Rats; Rats, Nude; Reactive Oxygen Species; Regeneration; Time Factors; Vascular Endothelial Growth Factor A

2014
Targeting survival pathways to create infarct-spanning bridges of human embryonic stem cell-derived cardiomyocytes.
    The Journal of thoracic and cardiovascular surgery, 2014, Volume: 148, Issue:6

    Topics: Animals; Cell Differentiation; Cell Line; Cell Proliferation; Cell Survival; Cytoprotection; Disease Models, Animal; Embryonic Stem Cells; Graft Survival; Heme Oxygenase (Decyclizing); Humans; Molecular Targeted Therapy; Myocardial Contraction; Myocardial Infarction; Myocardium; Myocytes, Cardiac; Protoporphyrins; Rats, Nude; Signal Transduction; Time Factors; Up-Regulation; Ventricular Function

2014
Cardiac stem cell therapy: checkered past, promising future?
    The Journal of thoracic and cardiovascular surgery, 2014, Volume: 148, Issue:6

    Topics: Animals; Embryonic Stem Cells; Humans; Myocardial Infarction; Myocardium; Myocytes, Cardiac; Protoporphyrins; Ventricular Function

2014
Heme oxygenase-1 induction protects the heart and modulates cellular and extracellular remodelling after myocardial infarction in rats.
    Experimental biology and medicine (Maywood, N.J.), 2011, Volume: 236, Issue:12

    Topics: Animals; Apoptosis; Cardiotonic Agents; Cell Proliferation; Collagen; Enzyme Induction; Fibronectins; Heme Oxygenase-1; Male; Myocardial Infarction; Myocardium; Myocytes, Cardiac; Protoporphyrins; Rats; Rats, Wistar; RNA, Messenger; Transforming Growth Factor beta1; Vimentin

2011